Pursuant to Clause 9 of the COVID-19 Public Health Response (Point-of-care Tests) Order 2021 (“Order”), I, Dr Ashley Bloomfield, Director-General of Health, exempt the following point-of-care rapid antigen test from all prohibitions under clause 7 of the Order.
Product name(s): FlowFlex SARS-CoV-2 Antigen Rapid Test
Manufacturer (country): ACON Biotech (Hangzhou) Co., Ltd. (China)
Sample type(s): Nasal
Product configuration: Professional or self-test of any package size
Dated at Wellington this 31st day of March 2022.
Dr ASHLEY BLOOMFIELD, Director-General of Health, Ministry of Health.